哮喘的

基本解释 (translations)

asthmatic

与哮喘的相关的网络例句 [注：此内容来源于网络，仅供参考]

Raby, from Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, and colleagues from the Childhood Asthma Management Program Research Group.

Raby以及其来自儿童哮喘管理计画研究团体的同事指出，在儿童罹患哮喘的研究中，有关哮喘儿其与父系哮喘病史和并发空气传播途径过度反应症的关系之信息很少。

The study showed that self-blood injection could improve the IFN-γin asthmatic rats and restrain expression of IL-4. That meaned it could correct the disproportionality of Thl and Th2 in asthmatic rats and it could be one of the important mechanisms of the treatment of self-blood injection.

研究结论经络注血疗法能提高哮喘大鼠IFN-γ含量，抑制IL-4的表达，即对卵蛋白所致哮喘大鼠Th1／Th2的比例失调有纠正作用，是经络注血疗法治疗哮喘的重要机理之一。

The lab animals were divided into four groups:the control group, positive control group, Chinese medicine group, prednisone group. The purpose of this study was to investigate the accurated clinical effect and pharmacodynamics mechanism of "Shegan mahuang decoction "in the treatment of asthma , in this way, the prevention and treatment of asthma was based on the findings of the study.

同时设立正常组，哮喘组，加味射干麻黄汤治疗组，强的松治疗组，旨在探讨中药加味射干麻黄汤治疗哮喘的作用机理及疗效，为其在防治哮喘方面的进一步应用提供科学的依据。

Object: According to the theory of Traditional Chinese Medicine and Modern Medicine, set up the bronchial asthma models and observed the general clinical symptoms and the plasma content of ET, TXB2 and 6-keto-PGF1α in experimental guinea pigs, then, the changes of those can illuminate the mechanism of shegan mahuang syrup.

目的：通过对支气管哮喘豚鼠的实验研究，从内皮素、血栓素B_2(TXB_2)、6-酮-前列腺素F_(1α)6-keto-PGF_(1α的角度说明射干麻黄糖浆可以治疗豚鼠支气管哮喘及其治疗豚鼠支气管哮喘的机理。

Half of children with asthma had otitis media in the first year of life, compared with 40% of children without asthma. Likewise, 7% of children with asthma had pneumonia and 9% had sinus infection, compared with 2% and 4% respectively in nonasthmatic children.

一半患哮喘的儿童和40%没有患哮喘的儿童在其1岁时有过中耳炎病史。7%的儿童哮喘患者有过肺炎病史，9%有鼻窦炎病史，未患哮喘组分别为2%和4%。

If the second signal overstimulate, T lymphocyte cells may be over- activated and lead to immune disorder.

本研究从共刺激分子在哮喘外周血表达和细胞因子的变化出发，分析它们与哮喘发病的相关关系，研究哮喘发病的可能免疫机制，为判断病情变化和临床哮喘的治疗提供理论依据。

The pathogenesis of asthma can be divided into three stages in immunology. The initial stage is sensibilization, which is closely associated with the activation of T cells. B7/CD28 and CD69 also play a significant role in this process. The second stage is chronic allergic inflammation. The immune dysfunction resulting from the disturbance of TH1/TH2 is a major cause of chronic allergic inflammation, and dominates asthma attack. And the third stage is airway remodeling due to chronic inflammation. Airway remodeling is one of the major causes of refractory asthma, which also contributes to the death from asthma.

哮喘的发病从免疫学角度可以分为三期：初期为致敏阶段，与T细胞激活关系密切，B7/CD28和CD69在这一过程也扮演重要角色；第二期为慢性过敏性炎症阶段，TH1/TH2失衡导致免疫功能紊乱是此阶段的主要原因，在哮喘发作过程中起主要作用；第三期为慢性炎症引起的气道结构重构阶段，是难治性支气管哮喘的重要发病和死亡原因。

Moreover, after being followed up for 3 years, 49 patients who received regular SIT have less possibility to suffer from asthma than those of 23 cases patients who had irregular SIT, and the difference between them was statistically significant (P.01). For AR patients complicating with asthma, their asthmatic symptoms and physical signs had been improved after SIT. It was increasingly reduced for the level of TIgE, SIgE, and ECP in serum of AR patients after SIT.

此外，观察期满3年的49例接受系统免疫治疗的患者与未系统治疗患者23例发现，前者继发哮喘的几率低于后者，两者比较差异有统计学意义(P.01)；对合并有哮喘的AR患者经SIT后，哮喘症状体征有改善；患者血清TIgE、SIgE和ECP在SIT治疗后水平逐渐降低。

BE1 monoclonal antibody can be used to detect basophils in tissue.

BB1单克隆抗体可有效地用于支气管肺组织标本的嗜碱性粒细胞免疫组织化学检测，同时急性发作的致死性哮喘患者气道中嗜碱性粒细胞明显增加，可能与哮喘病情恶化、甚至死亡有关，而非致死性的慢性哮喘患者气道中嗜碱性粒细胞与对照组无异，说明嗜碱性粒细胞可能主要参与哮喘的急性病程。

The dramatic increase in asthma prevalence in westernised countries in recent decades, and the development of asthma in susceptible individuals who have migrated to a western country, suggests that environmental factors, such as dietary intake, must play a role in the onset and development of the disease.

近几十年，西方国家的哮喘发病率呈现急剧增长，而且移居西方国家的一些易感人群也出现哮喘症状，这表明环境因素，如饮食摄入，在哮喘的发作和发展中起到了重要作用。

与哮喘的相关的网络解释 [注：此内容来源于网络，仅供参考]

asthmatic：哮喘的

Wheezingly 哮喘地 喘息地 | asthmatic 哮喘的 | proteolytic 蛋白水解的

asthmatic：哮喘的, 患哮喘症

asthma | 哮喘 | asthmatic | 哮喘的, 患哮喘症 | asthmatoid | 似气喘的, 气喘性的

asthmatic：患哮喘症

asthmatic 哮喘的 | asthmatic 患哮喘症 | asthmogenic 气喘原的

Asthmatic bronchitis：哮喘性支气管炎

哮喘性支气管炎(asthmatic bronchitis)是指婴幼儿时期有哮喘表现的支气管炎. 其特点是:1、多见于3岁以下,有湿疹或其他过敏史者;2、有类似哮喘的症状,如呼气性呼吸困难,肺部叩诊呈鼓音,听诊两肺满布哮鸣音及少量粗湿啰音;3、有反复发作倾向,

cromorna：(发出像单簧管音的)管风琴音栓

cromolyn sodium | 色甘酸钠(用于预防支气管哮喘的发作) | cromorna | (发出像单簧管音的)管风琴音栓 | Cromwell | 克伦威尔

asthmatoid：似气喘的

asthmatic 哮喘的 | asthmatoid 似气喘的 | astigmatic 乱视的

asthmatoid：似气喘的, 气喘性的

asthmatic | 哮喘的, 患哮喘症 | asthmatoid | 似气喘的, 气喘性的 | asthore | 亲爱的,我的宝贝

asthmogenic：气喘原的/致气喘的

asthmatic /哮喘的/患哮喘症/ | asthmogenic /气喘原的/致气喘的/ | astigmatic /乱视的/散光的/

proteolytic：蛋白水解的

asthmatic 哮喘的 | proteolytic 蛋白水解的 | Obstruction 阻塞

Wheezingly：哮喘地 喘息地

Hyperplasia 增生 | Wheezingly 哮喘地 喘息地 | asthmatic 哮喘的